Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing

Victoria L. Vetter; Josephine Elia; Christopher Erickson; Stuart Berger; Nathan Blum; Karen Uzark; Catherine L. Webb

doi:10.1161/CIRCULATIONAHA.107.189473

Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing

Victoria L. Vetter, Josephine Elia, Christopher Erickson, Stuart Berger, Nathan Blum, Karen Uzark, Catherine L. Webb

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	2407-2423
Number of pages	17
Journal	Circulation
Volume	117
Issue number	18
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.107.189473
State	Published - May 2008

Keywords

AHA Scientific Statements
Attention deficit disorder with hyperactivity
Cardiovascular monitoring
Congenital heart disease
Death, sudden
Heart arrest
Pediatrics
Stimulant drugs

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.107.189473

Cite this

Vetter, V. L., Elia, J., Erickson, C., Berger, S., Blum, N., Uzark, K., & Webb, C. L. (2008). Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing. Circulation, 117(18), 2407-2423. https://doi.org/10.1161/CIRCULATIONAHA.107.189473

Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs : A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing. / Vetter, Victoria L.; Elia, Josephine; Erickson, Christopher; Berger, Stuart; Blum, Nathan; Uzark, Karen; Webb, Catherine L.

In: Circulation, Vol. 117, No. 18, 05.2008, p. 2407-2423.

Research output: Contribution to journal › Review article › peer-review

Vetter, VL, Elia, J, Erickson, C, Berger, S, Blum, N, Uzark, K & Webb, CL 2008, 'Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing', Circulation, vol. 117, no. 18, pp. 2407-2423. https://doi.org/10.1161/CIRCULATIONAHA.107.189473

Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing. Circulation. 2008 May;117(18):2407-2423. https://doi.org/10.1161/CIRCULATIONAHA.107.189473

Vetter, Victoria L. ; Elia, Josephine ; Erickson, Christopher ; Berger, Stuart ; Blum, Nathan ; Uzark, Karen ; Webb, Catherine L. / Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs : A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing. In: Circulation. 2008 ; Vol. 117, No. 18. pp. 2407-2423.

@article{409c6bee483746708acef0a87aafaadb,

title = "Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing",

keywords = "AHA Scientific Statements, Attention deficit disorder with hyperactivity, Cardiovascular monitoring, Congenital heart disease, Death, sudden, Heart arrest, Pediatrics, Stimulant drugs",

author = "Vetter, {Victoria L.} and Josephine Elia and Christopher Erickson and Stuart Berger and Nathan Blum and Karen Uzark and Webb, {Catherine L.}",

year = "2008",

month = may,

doi = "10.1161/CIRCULATIONAHA.107.189473",

language = "English (US)",

volume = "117",

pages = "2407--2423",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "18",

}

TY - JOUR

T1 - Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs

T2 - A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing

AU - Vetter, Victoria L.

AU - Elia, Josephine

AU - Erickson, Christopher

AU - Berger, Stuart

AU - Blum, Nathan

AU - Uzark, Karen

AU - Webb, Catherine L.

PY - 2008/5

Y1 - 2008/5

KW - AHA Scientific Statements

KW - Attention deficit disorder with hyperactivity

KW - Cardiovascular monitoring

KW - Congenital heart disease

KW - Death, sudden

KW - Heart arrest

KW - Pediatrics

KW - Stimulant drugs

UR - http://www.scopus.com/inward/record.url?scp=43249096555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43249096555&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.107.189473

DO - 10.1161/CIRCULATIONAHA.107.189473

M3 - Review article

C2 - 18427125

AN - SCOPUS:43249096555

VL - 117

SP - 2407

EP - 2423

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 18

ER -